Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.
about
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesOverview of the 3rd isirv-Antiviral Group Conference--advances in clinical managementNosocomial transmission of respiratory syncytial virus in an outpatient cancer center.Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit.Respiratory Tract Infections Due to Human Metapneumovirus in Immunocompromised ChildrenViral infection is not uncommon in adult patients with severe hospital-acquired pneumoniaIdiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesComparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital.A patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipientsMoving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials.Management of respiratory viral infections in hematopoietic cell transplant recipients.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation.Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression.Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.Cytomegalovirus pneumonia in hematopoietic stem cell recipients.Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea.Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcomeThe impact of infection and tissue damage in solid-organ transplantation.Opportunistic viral infections in intestinal transplantation.The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens.Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution.Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.Antiviral therapy for respiratory viral infections in immunocompromised patients.Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.Human Metapneumovirus Infection in Immunocompromised Patients.The Expression of IL-6, TNF-α, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.Comparison of the direct fluorescence assay and real-time polymerase chain reaction for the detection of influenza virus A and B in immunocompromised patients.Prolonged respiratory viral shedding in transplant patients.Epidemiology of viral respiratory tract infections in an outpatient haematology facility.Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT.The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing.
P2860
Q26853131-8261DC2F-8CAD-4BF2-AA4F-FF32673677EDQ30368680-6A3CEF5E-3D75-4F80-AE96-0D59918A7A41Q33677479-D08B11BB-3188-4A1C-8C4B-B206D8B91354Q34214867-64617F05-C0E6-4BFD-8C5C-3D46C72EDA25Q34556228-C79F29CE-E0D3-4A1E-B2ED-4F76DF1DFFB9Q35154038-C7BD0066-F8BF-407B-995E-C11AA0A30B2FQ35724040-6D84B75B-4434-4EB9-A33C-6DAE020B7EE7Q36118576-9E512F73-1E96-4B49-B1A1-D8321D6FE810Q36238022-2A9B0D4A-99CE-429A-87A3-0CAD05D6EE50Q36438304-CF5AB6E1-7B74-4D10-809E-521C6224BFCDQ36439896-F89945F3-DC02-4C91-91D8-B2BBD412A55AQ36558322-5D3DA943-9869-4AA7-9C49-B06783549C6EQ36568965-7B96E43E-4D77-402A-91C5-5B3726F96988Q37055033-6E4F17E8-458A-4ED6-A7A7-5D4CD7378E69Q37118406-4EB31FCC-DDFA-4C32-ADA2-D2C107134F61Q37179131-130D9500-F4D7-4CA6-84E9-60781B1FC3DEQ37622157-4CBC9E8A-6311-42DB-8182-6FDD8B041030Q37726073-A42FD57E-6198-4DB1-A2A3-ECA2A9E613E6Q38013050-0D91D202-B7F1-4C99-8577-B227D0D39FF5Q38097119-2DDFEAD1-4671-4281-86B9-060B8CE63F97Q38154928-AEFB066D-D057-4C07-BE6B-2C58014489B8Q38609821-5C08A62B-A152-4A60-BBAE-2B6AED55EE1DQ38853701-767D22C5-3672-430E-A945-0FE84C58FE3CQ39076394-FD3CDEB8-1D93-48C3-83A9-717578CB1700Q39193577-311F5023-626B-4E71-8D3C-E037EDCB8C75Q40055495-5BB7CD52-1956-4214-8E1F-F00E345FA9A0Q40080165-DA286059-A79F-42E2-A9F8-FB34F673C0B9Q40269318-BA734E49-446E-4809-A14D-DD8537F5C9AAQ40340012-BE8A096F-5454-4921-9D0F-A5CA04795062Q40721939-F1FB197A-BBDC-4102-AE45-1E23AB93EA38Q41103203-05B3904A-6331-44C6-8526-47B3F54D120DQ41778563-F249DA5A-2550-4DF9-BEE0-73A48F33DC90Q42238692-0633A4DB-FFDB-4926-903B-EF1A499A2B8BQ42245439-9E8ECCB9-034E-43A4-ACA9-0365DBC8CE53Q51874195-D2C09EBF-7CC2-4452-8DA0-126B61D8A529Q53130111-B47D19C8-8CB6-47BD-924D-0CD2BF45B28DQ54204894-F35C6349-D472-4C59-8DC4-6674896E9A2DQ55516322-6DC668ED-95F9-4DCD-8BF9-02DB64418DFB
P2860
Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Changing epidemiology of respi ...... d organ transplant recipients.
@ast
Changing epidemiology of respi ...... d organ transplant recipients.
@en
type
label
Changing epidemiology of respi ...... d organ transplant recipients.
@ast
Changing epidemiology of respi ...... d organ transplant recipients.
@en
prefLabel
Changing epidemiology of respi ...... d organ transplant recipients.
@ast
Changing epidemiology of respi ...... d organ transplant recipients.
@en
P2860
P1476
Changing epidemiology of respi ...... d organ transplant recipients.
@en
P2093
Angela P Campbell
Christian Renaud
P2860
P304
P356
10.1097/QCO.0B013E3283480440
P577
2011-08-01T00:00:00Z